The Discovery NM530 is a new generation of SPECT cameras equipped with semiconductor cadmium-zinctelluride (CZT) detector technology. It provides a shorter scan time and reduces the patient's radiation exposure wthout loss of image quality compared with the conventional Anger camera. Combined supine and prone imaging with the Discovery NM530c is useful for reducing the false-positive rate in the infero-posterior or inferolateral segment associated with supine imaging. As studied by multicenter registry, 74% sensitivity, 85% specificity, and 81% accuracy for left anterior descending coronary artery stenosis, 76% sensitivity, 89% specificity, and 85% accuracy for left circumflex coronary artery stenosis, and 72% sensitivity, 86% specificity, and 82% accuracy for right coronary artery stenosis were observed in detecting an angiographic diameter narrowing of ≥75% on visual estimation. Using a low-dose technetium-99m (185/370 MBq) 1-day protocol with an effective dose of ≤5 mSv, CZT SPECT demonstrated an acceptable diagnostic yield in detecting a significant coronary stenosis as assessed by fractional flow reserve (FFR). As for limiting to 92 coronary lesions in which FFR was measured, stress SPECT showed 77% sensitivity, 91% specificity, and 84% accuracy, whereas the diagnostic value decreased to 52% sensitivity, 68% specificity, and 58% accuracy based only on visual estimation of ≥ 75% diameter narrowing. In addition, the quantification of myocardial perfusion reserve derived by dynamic SPECT imaging using the Discovery NM530c may help identify balanced ischemia in patients with left main or 3-vessel disease.
M
yocardial perfusion imaging (MPI) with single-photon emission computed tomography (SPECT) is widely used not only for the diagnosis of coronary artery disease (CAD) but also for evaluating disease severity in clinical practice. Although interest in radiation exposure from medical imaging is increasing throughout the world, nuclear cardiologists are expected to reduce a patient's radiation exposure from MPI SPECT (1, 2) .
The new generation of SPECT cameras equipped with semiconductor cadmium-zinc-telluride (CZT) detector technology is reported to provide superior image quality, reduced acquisition times, and lower radiotracer doses than the conventional Anger camera (3) (4) (5) (6) .
Two dedicated CZT cameras, the Discovery NM530c (GE Healthcare, Haifa, Israel) and the D-SPECT (Spectrum Dynamics, Caesarea, Israel) are currently available for cardiac SPECT in clinical practice in Japan. In this review, I will focus on reports from Japan regarding the clinical performance of the Discovery NM530c.
Characteristics of the Discovery NM530c
The characteristics of the Discovery NM530c are described briefly as follows. The Discovery NM530c is equipped with a multiple-pinhole collimator and 19 stationary CZT detectors that simultaneously focus on the heart to maximize the efficiency of SPECT. The stationary array simultaneously acquires all the views necessary for tomographic reconstruction, saving the time required by conventional cameras for acquisitions while rotating around the subjects (6). The energy resolution and spatial resolution are improved by a factor of 2, and sensitivity by a factor of almost 4, compared with the conventional Anger camera (3). The Discovery NM530c enables the acquisition of images not only in the supine position but also in the prone position. Images were reconstructed on a dedicated workstation (Xeleris, GE Healthcare) with an iterative algorithm using the maximum a posteriori expectation maximization method. In addition, a shorter acquisition-time image can be reconstructed using listmode.
Comparison of the Discovery NM530c with the standard

Anger camera
We prospectively compared the diagnostic performance of the Discovery NM530c with a standard 3-head gamma camera in 150 consecutive patients who underwent a 1-day stressrest 99m Tc-sestamibi or 99m Tc-tetrofosmin imaging protocol.
The radioisotope dosages were 296-370 MBq for stress imaging and 740 MBq for rest imaging. The image acquisition times were 5 and 3 minutes (stress and rest, respectively) using the Discovery NM530c compared with 15 minutes for each Hida Clinical Performance of the Discovery NM530c
Ann Nucl Cardiol 2016；2（1） ：125-130 -126 - Sensitivity, specificity, and accuracy for detecting CAD (≥70% luminal narrowing) were analyzed. When the diagnostic value of CZT SPECT imaging was limited to 76 patients in whom CAG was performed, combined supine and prone imaging had a significantly higher specificity (82% vs 50%; p<0.001) and accuracy (85% vs 76%; p=0.035) without loss of sensitivity (85% vs 87%) than supine imaging alone.
On a per-vessel analysis, the sensitivity and specificity of the combined supine and prone imaging were 53% and 81% for left anterior descending artery (LAD) stenosis, 72% and 66%
for left circumflex (LCx) stenosis, and 74% and 68% for right coronary artery (RCA) stenosis, respectively. infero-lateral segment associated with supine imaging, and has diagnostic value for detecting obstructive CAD.
Comparison of myocardial image quality and counts between low-dose and standard dose scans
A CZT camera has the potential to shorten the scan time and reduce a patient's radiation exposure. We prospectively compared the myocardial counts and image quality at a low- at the 4-minute scan time (Fig. 2b) . Myocardial counts were similar between the standard dose scan and the low-dose scan with twice as much as the standard dose scan-time in both stress imaging and rest imaging (9) . These results suggest that low-dose scan with a longer scan time obtains higher myocardial counts and reduces a patient's radiation exposure without loss of image quality.
Diagnostic performance of the Discovery NM530c as studied by multicenter registry
To assess the diagnostic performance of the Discovery NM530c for a large number of patients, we formed a working group that was supported by the Japanese Society of Nuclear
Medicine from 2012 to 2014, and registered 1,000 patients from 4 institutions. The methods for inducing stress were exercise in 153 patients (15%) and vasodilator pharmacologic stress in 847 patients (85%). 99m Tc-radiotracer was used in 711 patients (71%) and 201 Tl in 289 patients (29%). Significant coronary stenosis was defined as ≥75% diameter narrowing on visual estimation. In all of the 1, 000 patients, 74%
sensitivity, 85% specificity, and 81% accuracy for LAD stenosis, 76% sensitivity, 89% specificity, and 85% accuracy for LCx stenosis, and 72% sensitivity, 86% specificity, and 82% accuracy for RCA stenosis were observed. According to the radiotracers, in the 711 patients in whom 99m Tc-radiotracer was used, the respective sensitivities, specificities, and accuracies were 66%, 91%, and 83% for LAD stenosis, 76%, 90%, and 87% for LCx stenosis, and 65%, 91%, and 85% for RCA stenosis. In contrast, in the 289 patients in whom 201 Tl was used, the respective sensitivities, specificities, and accuracies were 88%, 63%, and 75% for LAD stenosis, 76%, 86%, and 82% for LCx stenosis, and 82%, 71%, and 75% for RCA stenosis (10) . These results suggest that the diagnostic sensitivity for LAD with 201 Tl may be superior to that with Ann Nucl Cardiol 2016；2（1） ：125-130 -128 -estimation, or as a lesion of <90% and ≥50% stenosis with an FFR of ≤ 0. 80. To detect individual coronary stenosis, the respective sensitivities, specificities, and accuracies were 86%, 75%, and 82% for LAD stenosis, 76%, 81%, and 79%
for LCx stenosis, and 87%, 92%, and 90% for RCA stenosis.
As for limiting to 92 coronary lesions in which FFR was measured, stress SPECT showed 77% sensitivity, 91% specificity, and 84% accuracy, whereas the diagnostic value decreased to 52% sensitivity, 68% specificity, and 58% accuracy based only on visual estimation of ≥75% diameter narrowing (15) . Even using a low-dose technetium-99m On multivariate analysis, it was found that an MPR index ≤1.5
yielded the highest diagnostic accuracy (odds ratio: 82.3, p= 0.005). For predicting left main disease and 3-vessel disease, the sensitivity, specificity, and accuracy were 86%, 78%, and 80% for the MPR index. The quantification of MPR using the Discovery NM530c may help identify balanced ischemia in patients with left main or 3-vessel disease.
Conclusions
The Discovery NM530c, which is one of the new generations of SPECT cameras equipped with CZT detector technology, has been introduced in Japan about 5 years ago.
The Discovery NM530c provides superior image quality, reduced acquisition time, and lower radiotracer dose than the conventional Anger camera and shows an acceptable diagnostic accuracy in detecting a significant coronary stenosis not only on visual estimation of ≥ 75% diameter narrowing but also as assessed by FFR. In the future, further reduction in either the scan time or the tracer dose may be possible, even when using a low-dose technetium-99m
protocol. Furthermore, the estimation of MFR using the CZT SPECT system may be possible by the accumulation of clinical research.
